SCHEMBL29723948

SCHEMBL29723948

CCOC(=O)C(=O)c1c(F)cccc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
ALOX15 P16050 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
LMNA P02545 1/20 0.46
POLB P06746 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
KDM4E B2RXH2 1/20 0.45
TSHR P16473 1/20 0.45
KMT2A Q03164 4/20 0.44
GAA P10253 4/20 0.44
MEN1 O00255 3/20 0.44
ATM Q13315 1/20 0.44
GPR35 Q9HC97 1/20 0.44
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
CASP1 P29466 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
MAPT P10636 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10441996 1.00 ALDH1A1 (0.47) ALDH1A1ALOX15TDP1LMNAPOLB
SCHEMBL6640647 0.91 ALDH1A1 (0.45) ALDH1A1ALOX15TDP1LMNAPOLB
SCHEMBL14605537 0.89 CES2 (0.57) ALDH1A1TDP1LMNASMN1; SMN2KDM4E
SCHEMBL5528116 0.89 GPR35 (0.50) ALDH1A1TDP1LMNAPOLBSMN1; SMN2
SCHEMBL1671664 0.84 LMNA (0.58) ALDH1A1ALOX15TDP1LMNAPOLB
SCHEMBL5776628 0.83 GAA (0.42) ALDH1A1ALOX15TDP1LMNAPOLB
SCHEMBL5776625 0.83 GAA (0.42) ALDH1A1ALOX15TDP1LMNAPOLB
SCHEMBL23301981 0.82 ALDH1A1 (0.43) ALDH1A1ALOX15TDP1LMNAPOLB
SCHEMBL16563920 0.82 MEN1 (0.52) ALDH1A1ALOX15TDP1LMNAPOLB
SCHEMBL23301982 0.82 ALDH1A1 (0.43) ALDH1A1ALOX15TDP1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114630826-A Fluorinated quinoline, quinoxaline and benzo [ b ] [1,4] oxazine derivatives as dihydroorotate dehydrogenase (DHODH) inhibitors for the treatment of cancer, autoimmune and inflammatory diseases 詹森生物科技公司 2022-06-14 CN disclosed